Delivery Order SPE2DB22D9229-SPE2DB24FU2HS

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $10,634.16, is for the delivery of PREVNAR 20 SYRINGE 0.5ML under a firm fixed-price delivery order contract. The contract does not have a set-aside designation and has an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,722.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is to provide PREVNAR 20 SYRINGE 0.5ML, a pharmaceutical product, with a period of performance through July 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,850.55 firm fixed-price delivery order is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pneumococcal conjugate vaccine, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award, with an ID of SPE2DB20D9766|SPE2DB25FC1FH, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $35,084.40 firm fixed-price delivery order is for the supply of PREVNAR 20 SYRINGE 0.5ML, a pharmaceutical product, with a completion date of April 9, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award, valued at $26,583.30, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of PREVNAR 20 SYRINGE 0.5ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger Indefinite Delivery Contract (IDC) valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,089.44, is for the delivery of PREVNAR 20 SYRINGE 0.5ML to support the recurring medical supply needs of military health facilities. This order is issued under a larger single-award indefinite delivery contract (IDC), valued at up to $499,999,999, that DMS...
This federal contract award, with an ID of SPE2DB22D9304|SPE2DB24FSSY2, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,692.04 firm fixed-price delivery order is for the supply of PREVNAR 20 SYRINGE 0.5ML, a prescription pharmaceutical product, with a completion date of July 9, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Prevnar 20 syringes, a pneumococcal vaccine, valued at $7,088.88. The contract has an ultimate completion date of July 10, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, which is a $499,999,999 Indefinite Delivery Contract (IDC) that allows the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,317.08, is for the delivery of PREVNAR 20 syringes (0.5 mL) to support the medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that...
  • SPE2DB22D9229
    Indefinite Delivery Contract
  • SPE2DB22D9229-SPE2DB24FU2HS
    Delivery Order

This federal contract award, valued at $1,772.22, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for PREVNAR 20 SYRINGE 0.5ML, with a firm fixed-price pricing type and a completion date of July 8, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract is not associated with any set-aside designation.

Generated 5/17/25, 10:02 AM